We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Rapid DNA Analysis Identifies Alleged Child Rapist

By Biotechdaily staff writers
Posted on 22 Mar 2007
A new DNA testing program has led to the prompt identification and apprehension of an individual charged with raping an 11-year old girl at her Olympia, WA (USA) home late last month. More...
The first application of this rapid DNA analysis program resulted in the identification of a suspect in less than one week.

The program was implemented by the Washington State Association of Sheriffs and Police Chiefs (WASPC; WA, USA) and Orchid Cellmark (USA). The new Washington State program, made possible by special Congressional funding, is designed to ensure that DNA rape kits involving stranger rapes are analyzed within 30 days. Nationwide, DNA analysis can typically take six to twelve months, and an estimated 220,000-backlogged DNA rape kits in the United States have never been analyzed at all.

In contrast, this rapid DNA analysis program identified the alleged rapist in less than a week, leveraging good investigative work by the Olympia police force, which produced a DNA sample from a suspect that Orchid Cellmark quickly identified as belonging to the rapist. This same DNA analysis also ruled out an innocent neighbor, who had initially been charged with the crime, but who under the new program was exonerated and set free within days, not the months that could have been required in the past.

This early success in our Stranger Rape DNA Project illustrates how effective a rapid DNA analysis program can be, said Don Pierce, executive director of the WASPC, sponsor of the program. We are pleased that Washington State's Congressional delegation has helped us become the first state in the nation to implement this innovative program. By partnering with Orchid Cellmark on this project, we hope to make Washington a safer place to live.

Mark Stolorow, forensic DNA expert at Orchid Cellmark noted, As one of the largest private DNA testing labs [in the US], we have long advocated greater public/private collaboration to increase law enforcement's access to rapid DNA testing. We also had the advantage of being able to leverage our experience [in the UK], where rapid DNA testing is the norm, to design our new rapid turnaround service [in the US]. Our colleagues in Washington were the first in the nation to understand the potential of our rapid DNA testing initiative and to take action to implement it.


Related Links:
Orchid Cellmark
WASPC

New
Gold Member
Automatic Hematology Analyzer
CF9600
New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
New
Prefilled Tubes
Prefilled 5.0ml Tubes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Plasma pTau217 testing can predict future amyloid accumulation and cognitive decline in cognitively healthy older adults (photo courtesy of Shutterstock)

Blood Test Predicts Alzheimer Disease Risk Before Imaging Changes and Symptoms

Alzheimer's disease often advances silently for years, making timely risk stratification difficult in routine practice. Current approaches to detect pathology can involve lumbar puncture or positron emission... Read more

Industry

view channel
Image: Pathlight combines WGS and dPCR to identify and longitudinally track large‑scale genomic changes, known as structural variants (photo courtesy of SAGA Diagnositcs)

Roche Affiliate Expands MRD Portfolio with SAGA Acquisition

Foundation Medicine, Inc., an independent affiliate of Roche, announced plans to expand its monitoring portfolio with SAGA Diagnostics’ Pathlight, a personalized, tumor-informed molecular residual disease... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.